Alveolus Inc.

Alveolus Inc. is focused on stenting obstructed airways and other nonvascular lumens with a removable self-expanding metal stent that can be placed with direct visualization. The company believes that in addition to improving the quality of life for terminally ill cancer patients, its products can potentially be used as temporary, minimally invasive treatments in many diseases characterized by benign lumenal obstructions.